Valuation: Avantor, Inc.

Capitalization 7.76B 6.68B 6.16B 5.9B 10.88B 688B 11.85B 73.26B 28.2B 328B 29.1B 28.5B 1,199B P/E ratio 2025 *
-15.6x
P/E ratio 2026 * 21.9x
Enterprise value 11.18B 9.63B 8.87B 8.5B 15.68B 992B 17.07B 106B 40.65B 473B 41.94B 41.08B 1,728B EV / Sales 2025 *
1.71x
EV / Sales 2026 * 1.64x
Free-Float
96.65%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
Manager TitleAgeSince
Chief Executive Officer 55 2025-08-17
Director of Finance/CFO 55 2023-08-06
Compliance Officer 57 2023-06-30
Director TitleAgeSince
Chairman 67 2022-05-11
Director/Board Member 60 2019-08-31
Director/Board Member 59 2020-04-21
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-2.74%-1.47% - - 7.76B
+1.03%+3.35%+13.53%+28.02% 227B
-0.28%+3.98%+11.48%+15.65% 123B
-0.80%+0.34%+48.70%+133.92% 70.17B
0.00%+8.55%-15.02%-13.88% 55.33B
-0.58%-4.93%+20.89%+60.70% 52.95B
-0.78%-2.03%+16.83%+54.02% 25.36B
+0.01%+4.03%+27.39%+14.69% 23.4B
-0.46%-4.87%-22.29%+16.49% 22.66B
-2.78%+5.56%-22.25%-48.61% 22.64B
Average -0.74%+1.25%+8.80%+29.00% 63.03B
Weighted average by Cap. -0.00%+2.43%+13.23%+33.92%
See all sector performances

Financials

2025 *2026 *
Net sales 6.53B 5.62B 5.18B 4.96B 9.15B 579B 9.96B 61.62B 23.72B 276B 24.47B 23.97B 1,009B 6.54B 5.63B 5.19B 4.97B 9.17B 580B 9.98B 61.74B 23.77B 277B 24.52B 24.02B 1,011B
Net income -501M -431M -397M -381M -702M -44.41B -765M -4.73B -1.82B -21.2B -1.88B -1.84B -77.41B 348M 300M 276M 265M 488M 30.87B 532M 3.29B 1.27B 14.74B 1.31B 1.28B 53.81B
Net Debt 3.42B 2.95B 2.72B 2.6B 4.8B 304B 5.23B 32.32B 12.44B 145B 12.84B 12.58B 529B 2.98B 2.57B 2.36B 2.26B 4.18B 264B 4.55B 28.14B 10.83B 126B 11.17B 10.95B 461B
More financial data * Estimated data
Logo Avantor, Inc.
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Employees
13,500
More about the company
Date Price Change Volume
25-11-14 11.38 $ -2.74% 8,241,558
25-11-13 11.70 $ +1.30% 7,909,631
25-11-12 11.55 $ +0.43% 6,338,203
25-11-11 11.50 $ 0.00% 6,469,529
25-11-10 11.50 $ -0.43% 6,723,611

Delayed Quote Nyse, November 14, 2025 at 04:00 pm EST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
11.38USD
Average target price
13.64USD
Spread / Average Target
+19.88%
Consensus

Quarterly revenue - Rate of surprise